Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ludmila Archakova"'
Autor:
Eugene Sokolovich, Alexey D. Ushkov, Igor Mamenko, Piotr Yablonskii, Tatiana Novickaya, Igor Vasilev, Irina Tabanakova, Irina Vikulova, Ludmila Archakova, Vera Shevel
Publikováno v:
Journal of Bronchology & Interventional Pulmonology. 25:60-62
We report a case of metastatic pulmonary calcification in a patient with chronic renal failure on hemodialysis and secondary hyperparathyroidism. The diagnosis was made by using a probe-based confocal endomicroscopy which showed specific structures i
Autor:
Oleg N Resnik, Larisa D Kiruhina, Ludmila Archakova, Igor Vasilev, Alexey D. Ushkov, Grigorii Kudriashov, Armen Avetisyan, Piotr Yablonskii, Tatyana A Novickaya
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 22:704-705
Autor:
Irina Chernokhaeva, Ludmila Archakova, Anna Starshinova, Tatiana Vinogradova, Maria Pavlova, Nadezda Sapozhnikova, Piotr Yablonskii
Publikováno v:
10.2 Tuberculosis.
Introduction: In accordance to international classification Tioureidoiminomethylpyridinium perchlorate ( Perchlozon) belongs to thioacetazone group [D.Tomas, 2014] . Objective: to confirm data on safety and efficacy of Tioureidoiminomethylpyridinium
Autor:
T. I. Vinogradova, N. V. Sapozhnikova, Yu. N. Levashev, Piotr Yablonskiy, I. V. Chernokhaeva, M. L. Vitovskaya, N. V. Zabolotnykh, Pavlova Mv, A. A. Starshinova, E. K. Zilber, Ludmila Archakova
Publikováno v:
Терапевтический архив, Vol 88, Iss 3, Pp 111-115 (2016)
ResearcherID
ResearcherID
The paper sets forth the stages of design and introduction of the new Russian tuberculosis (TB) drug perchlozon registered in the Russian Federation in 2012. Based on the results of Phases I-III clinical trials, the authors evaluate the efficacy and